Endoscopic third ventriculostomy for obstructive hydrocephalus by Dixon, Hassan Z.A. et al.
 DOI: 10.33962/roneuro-2020-039 
Endoscopic third ventriculostomy for 
obstructive hydrocephalus 
Hassan Z.A. Dixon, 
Yasir M. Hamandi, 
Ammar M.A. Mahmmoud, 
Samer S. Hoz, 
Zahraa F. Al-Sharshahi 
Romanian Neurosurgery (2020) XXXIV (1): pp. 269-274 
DOI: 10.33962/roneuro-2020-039 
www.journals.lapub.co.uk/index.php/roneurosurgery 
 
 
 
Endoscopic third ventriculostomy for 
obstructive hydrocephalus  
 
 
Hassan Z.A. Dixon1, Yasir M. Hamandi2, Ammar M.A. 
Mahmmoud3, Samer S. Hoz4, Zahraa F. Al-Sharshahi5 
 
1 Neurosurgeon F.I.C.M.S., Al-Mawanee General Hospital, Basra, IRAQ 
2 Professor of Neurosurgery, Al-Nahrain College of Medicine, 
Baghdad, IRAQ 
3 Neurosurgeon, Neurosurgery Teaching Hospital, Baghdad, IRAQ 
4 Neurosurgeon (FRCS), Department of Neurosurgery, Neurosurgery 
Teaching Hospital, Baghdad, IRAQ 
5 MB, BCh BAO (NUI, RCSI), LRCP & SI, Royal College of Surgeons in 
Ireland (Alumnus), Dublin, IRELAND 
 
 
 
ABSTRACT 
Introduction: Obstructive hydrocephalus has long been managed by valve-
regulated shunts. These shunts are associated with a myriad of short and long-term 
complications. This has fuelled interest in Endoscopic Third Ventriculostomy (ETV) 
which provides a more physiological pathway for cerebrospinal fluid (CSF) diversion 
while avoiding many shunt-related complications. 
Aim: The objective of this study is to analyse the outcomes of ETV at our institution, 
focusing on the indications, success rates, and short-term complications. 
Methods: Between July 2010 and September 2015, 47 patients with obstructive 
hydrocephalus underwent ETV at the Neurosurgery Teaching Hospital in Baghdad/ 
Iraq. We retrospectively analysed the data of these patients using hospital health 
records. Simple statistics were performed using SPSS Version 20. A standardized 
surgical technique was employed in all cases. 
Results: The mean age was 4.4 years (range 40 days - 38 years). The male: female 
ratio was 1.23:1 (55% males and 45% females). The most common cause of 
obstructive hydrocephalus in patients undergoing ETV was aqueductal stenosis (62%; 
N=29). The second most common cause was posterior fossa tumours (23%; N=11). 
The overall success rate for ETV was 68%. The net post-operative complication rate 
was 13% (N=6). CSF leak and seizures were the only two charted post-operative 
complications at the rates of 9%(N=4) and 4% (N=2), accordingly. No deaths were 
recorded. 
Conclusion: ETV is a viable alternative to shunt insertion in a select group of patients 
with obstructive hydrocephalus, with acceptable success rate and safety profile. 
. 
 
INTRODUCTION 
Hydrocephalus is a condition that results when excess cerebrospinal 
fluid (CSF) accumulates in the cerebral ventricles resulting in ventricular 
dilatation and raised intracranial pressure (Lu, Chen, Weng, & Xu, 2019). 
Hydrocephalus is divided into communicating and non-communicating 
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(Aka. obstructive) subtypes, as per Dandy's 
classification (Lu et al., 2019). Non-physiological CSF 
diversion using valve-regulated ventriculo-peritoneal 
and ventriculo-atrial shunts has dominated the field 
of hydrocephalus management over the past 45 
years. However, shunts come with many 
complications including infections, displacement, 
and hardware failure. Failure rates are reported at 
25-40 % in the first year then 5-10% per year 
thereafter (Deopujari, Karmarkar, & Shaikh, 2017). 
The significant morbidity imposed by these shunts 
and the need for frequent revisions has warranted 
the search for novel treatment options (Mugamba & 
Stagno, 2013).  
First introduced by mixter in 1923, Endoscopic 
Third Ventriculostomy (ETV) has regained popularity 
in the last two decades as an attractive treatment 
option for hydrocephalus (Mixter, 1923). In fact, ETV 
for the treatment of obstructive hydrocephalus is 
currently the most commonly performed 
endoscopic neurosurgical procedure (M. Gangemi et 
al., 1999) (Hellwig et al., 2005). Desirable qualities of 
ETV include 1) its physiological mechanism of CSF 
diversion, 2) its minimally invasive nature and 3) the 
absence of long-term hardware and all its associated 
complications (Mugamba & Stagno, 2013).  
Since it's advent in the early 1990s, ETV has 
shown the highest success rate amongst patients is 
obstructive hydrocephalus caused by acqueductal 
stenosis, both congenital and acquired (Mugamba & 
Stagno, 2013). Nonetheless, both the surgical 
techniques and indications for ETV are constantly 
being refined. In the last few decades, many authors 
have been calling to expand the indications for ETV 
and numerous reports have been published to 
support this notion. (Beems & Grotenhuis, 2004) 
(Brockmeyer, Abtin, Carey, & Walker, 1998) (Choi, 
Kim, & Kim, 1999) (Cinalli et al., 1999) (Feng et al., 
2004) (Grunert, Charalampaki, Hopf, & Filippi, 2003) 
(Scarrow, Levy, Pascucci, & Albright, 2000) 
(Schroeder, Niendorf, & Gaab, 2002) (Tisell, 
Almström, Stephensen, Tullberg, & Wikkelsö, 2000).  
In their systematic review and meta-analysis that 
compared the failure rates of obstructive 
hydrocephalus vs shunt insertion for patients with 
non-communicating hydrocephalus, Rasul et al 
concluded that ETV has statistically non-significant 
advantage over shunts; it does, however, appear to 
provide long-term survival benefit specifically in 
patients with congenital acqueductal stenosis (Rasul, 
Marcus, Toma, Thorne, & Watkins, 2013).  
In Iraq, ETV is still a relatively novel modality. In 
this paper, we aim to report our experience with ETV 
in the management of patients with obstructive 
hydrocephalus, which is one of the earliest reports in 
this field from our country.  
 
PATIENTS AND METHODS 
We conducted a retrospective analysis of a 
consecutive sample of 47 patients who underwent 
ETV for obstructive hydrocephalus at the 
Neurosurgery Teaching Hospital in Baghdad (NTH) 
for the period between July 2010 and September 
2015. The aim of this study was to determine the 
success rate of ETV at our institution and to identify 
the main complications. A clinicoradiological 
criterion was implemented in our study. Patients 
were deemed candidates for ETV if they 1) presented 
with symptoms related to hydrocephalus such as 
raised ICP or enlarging head circumference and 2) 
had an MRI-confirmed diagnosis of obstructive 
hydrocephalus. Patients with communicating 
hydrocephalus were excluded from the study. The 
follow-up period ranged between six months and six 
years (6 months-6 years). The success of ETV was 
defined by a combination of clinical and radiological 
criteria and ultimately by "shunt-independence". The 
clinical criteria revolved around the resolution of 
symptoms and signs caused by the high intracranial 
pressure by the 3-month follow-up visit. The 
radiological criteria were defined as the decrease in 
ventricular size or the arrest of ventriculomegaly as 
determined by Ultrasonography (US) and/or 
Computed Tomography (CT), using the Evans Index 
or the fronto-Occipital horn ratio. All data were 
obtained from the hospital health records at the NTH 
and statistics were performed using SPSS Version 20.  
 
OPERATIVE TECHNIQUE 
All operations were performed under general 
anesthesia. During each surgery, the fowling steps 
were followed:  
• The patient was placed in a supine position with 
the head resting on a doughnut-shaped head 
rest.  
• The head and neck were flexed at (15
o).  
• A Longitudinal skin incision was made just in front 
of coronal suture to the right of the mid-pupillary 
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line (3 cm off mid line & 1cm anterior to coronal 
suture).  
• The skin and periosteum were opened as a single 
layer with visual identification of coronal suture.  
• A burr hole was drilled abutting the anterior 
border of coronal suture. 
• The dura was coagulated and retracted in a 
cruciate fashion using a bipolar. 
• The pia and arachnoid were coagulated and 
opened sharply in a cruciate fashion. 
• The articulated arm of the endoscope was 
installed as close as possible to the patient’s head.  
• Warm ringer lactate solution was connected to 
the sheath at a height of 15 cm from the patient’s 
ear.  
• A Rigid sheath (8mm) with its trocar inside was 
advanced slowly into the brain tissue aiming the 
tip of the sheath at the inner canthus in 
mediolateral plane and towards the tragus in 
antero-posterior plane.  
• A sudden give up was used as an indication that 
the ventricle has been punctured. The trochar 
was then removed.  
• A telescope with an attached light source and 
camera (3S) was introduced inside the sheath and 
locked in the zero position. 
• The Foramen of Monro was identified, the arm 
was released and the sheath was introduced 
through foramen and placed just above the 
mammillary body.  
• The thinned floor of the 3rd ventricle at the region 
of the tuber cinereum was identified and 
punctured using the fenestration forceps.  
• The Ringer solutions was allowed to circulate in 
and out to verify the stoma opening.  
• The endoscope was then withdrawn slowly while 
visualising the entry track.  
• Cylindrical pieces of Gelfoam were placed in the 
track and on the burr hole followed by 
subcutaneous tissue and skin closure. 
 
RESULTS  
Our sample contained a heterogeneous group of 
patients in relation to the national geographic 
distribution, age range, and hydrocephalus etiology. 
The mean age was 4.4 years (range 40 days -38 
years). The male: female ratio was 1.23:1 (55% males 
and 45% females). The most common cause of 
obstructive hydrocephalus in patients undergoing 
ETV was acqueductal stenosis (62%; N=29). The 
second most common cause was posterior fossa 
tumors (23%; N=11). Other aetiologies included third 
ventricle arachnoid cyst (11%; N=5), choroid plexus 
tumor of the lateral ventricle (2%; N=1) and thalamic 
tumors (2%; N=1). The overall success rate for ETV 
was 68%. Subgroup analysis showed that success 
rates were 62% and 78% for patients with 
acqueductal stenosis and posterior fossa tumors, 
respectively. Regarding the age group, the success 
rate for the younger population (below 10 years) was 
(62-65%). In the subset of patients with unclear 
cerebrospinal fluid (CSF), the success rate was 22%. 
No intraoperative complications were encountered. 
The net post-operative complication rate was 13% 
(N=6) and spontaneous closure was charted in 32% 
(N=15). CSF leak and seizure were the only two 
recorded postoperative complications at the rates of 
9%(N=4) and 4% (N=2), accordingly. The mortality 
rate was 0% (N=0). None of the patients needed redo 
ETV or shunt insertion as per their corresponding last 
follow-up visits.  
 
 
Figure 1.  
A. nine-year-old 
female with 
obstructive 
hydrocephalus due to 
4th ventricular tumor 
(histopathologically 
proved WHO grade 4 
Ependymoma). A: Pre-
ETV axial T1-weighted 
brain MRI with 
contrast showing 
hydrocephalus with 
ballooning of the 3rd 
ventricle and dilatation 
of both the frontal and 
temporal horns of 
lateral ventricles.  
 
 
 
 
 
 
B: Early post-ETV brain 
CT scan (axial section) 
showing improvement 
of ventricular dilation 
with normal shape and 
size of the 3rd ventricle 
and the frontal horn of 
lateral ventricles. 
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DISCUSSION 
ETV is an important treatment option in the 
management of hydrocephalus. In our cohort of 47 
patients with obstructive hydrocephalus, the two 
most common indications for ETV were acqueductal 
stenosis and posterior fossa tumors; this 
corresponds to the results published by Bouras et.al 
in their systematic review and meta-analysis (T. 
Bouras & S. Sgouros, 2012).  
Recently, ETV has replaced extra-cranial shunts as 
the first-line treatment for occlusive hydrocephalus 
caused by acqueductal stenosis. Although the 
efficacy of ETV has been most established with the 
congenital forms of acqueductal stenosis, it is still a 
viable treatment option for other acquired 
aetiologies including those attributed to 
inflammatory and neoplastic processes (Hellwig et 
al., 2005). This finding was also reflected in our 
results, wherein patients with acqueductal stenosis 
had the highest success rates. 
ETV has also proven effective in the management 
of occlusive hydrocephalus in patients with posterior 
fossa tumors (Amano et al., 2002) (Ruggiero et al., 
2004) (Cinalli et al., 1999) (Schijman, Peter, Rekate, 
Sgouros, & Wong, 2004) (Sainte-Rose et al., 2001). 
The incidence of pre-operative hydrocephalus in 
these patients is estimated at 80%, with 25-30% 
progressing to persistent post-operative 
hydrocephalus necessitating surgical intervention 
(Hellwig et al., 2005). In their series of 206, Sainte-
Rose et al concluded that when performed prior to 
craniotomy, ETV reduced the incidence and 
progression of post-operative hydrocephalus 
(Sainte-Rose et al., 2001). However, there exists no 
consensus regarding the timing and the definitive 
treatment modality to be used in the management 
of these patients (Hellwig et al., 2005). 
Since it's advent in the late 1980s and early 1990s, 
much experience has been gained with ETV as a 
management tool in patients with obstructive 
hydrocephalus. On the other hand, the efficacy of 
ETV in communicating hydrocephalus has not been 
scientifically established and is currently under 
investigation, with some authors reporting 
encouraging results (Hailong et al., 2008) (Meier, 
Zeilinger, & Schönherr, 2000) (Michelangelo 
Gangemi, Maiuri, Buonamassa, Colella, & de Divitiis, 
2004). At our institution, patients with 
communicating hydrocephalus are not currently 
considered candidates for ETV.  
To date, patient selection criteria for ETV is a 
debatable issue in the neurosurgical community; i.e. 
there is no clear definition of "ETV-eligible" patients 
and patient selection is currently based on local 
institutional policies, individual surgeon's experience 
and patient preference. (M. Gangemi et al., 1999) 
(Triantafyllos Bouras & Spyros Sgouros, 2012).  
Evaluation of ETV outcome has been mainly 
based on a clinicoradiological criteria. Clinical criteria 
focus on symptomatic improvement and shunt-
independence while the radiological criteria centers 
on the reduction of the ventricular size and/or 
cessation of its growth (Buxton, Turner, Ramli, & 
Vloeberghs, 2002) (Deopujari et al., 2017). However, 
some recent evidence tells us that the change in 
ventricular size is an unreliable indicator, especially 
in the early postoperative period. (Schwartz, Yoon, 
Cutruzzola, & Goodman, 1996) (Feng et al., 2004). 
Success rates with ETV have been reported to be 
between 50-90% (Hellwig et al., 2005). Beams and 
Grotenhius have reported the largest series thus far 
on patients with ETV (339 cases). In the 
aforementioned series, shunt independence was 
charted in 258 patients, with a complication rate of 
7.7%. (Beems & Grotenhuis, 2004).  
Regarding factors that predict poor outcomes 
after ETV, a history of shunt infection and post-
operative meningitis have been identified as 
independent risk factors for ETV failure (Fukuhara, 
Vorster, & Luciano, 2000). None of our patients 
harbored either risk factor.  
Both the immediate and long-term complications 
associated with ETV are currently insufficiently 
reported in the literature to draw solid conclusions. 
There exist many inconsistencies in the reported 
intra-operative, immediate and delayed 
postoperative complications. In one systematic 
review, the mortality rate was reported as 0.22% and 
the permanent morbidity rate was 2.1%. The most 
common charted complications were CSF infections 
(1.8%) and CSF leak (1.7%) (T. Bouras & S. Sgouros, 
2012). Further studies have also reported mortality 
rates below 1% (Cohen, 1994; M. Gangemi et al., 
1999; Jones, Kwok, Stening, & Vonau, 1994; Teo & 
Jones, 1996). In our study, no deaths were recorded 
as per the last follow-up visit for each patient.  
The obvious shortcomings in our study are 1) the 
short follow-up period and 2) the small cohort size. 
In fact, these two limitations are shared by the 
majority of the related reports in the literature, an 
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observation that highlights the need for multi-center, 
prospective, long-term studies to elucidate the long-
term outcomes of ETV.  
 
CONCLUSION 
ETV is a promising treatment strategy for patients 
with obstructive hydrocephalus. However, many 
questions remain unanswered in relation to its long-
term efficacy and safety, calling for further research 
in this area.  
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